|Theme:||Health Driving to Connect the World|
|Time:||15:00-18:30 on June 9, 2021 (Beijing time)|
|On-site venue:||Ningbo City, Zhejiang Province, China
(Online conference will be held simultaneously )
|Participants:||International politicians, leaders of relevant central ministries and commissions of China; Fortune 500 companies, listed companies, and Chinese state-owned enterprises; well-known academicians, scientists, and technology leaders; international health industry investors; leaders of the Zhejiang Provincial Party Committee and Provincial Government, etc.|
|Key areas:||Biopharmaceuticals, medical devices, medical testing, biological vaccines, precision treatment, high-end medical treatment, health management service, health products etc.|
Dr. Tae Han Kim
Hak Cheol Shin
Pius S. Hornstein
The Shanghai Immune Therapy Institute was established on Thursday as part of the city's efforts to accelerate developing basic and translational research in the immunological field to promote the city's biomedical industry.
SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A genetic
German investor Christian Angermayer is planning to list a blank-cheque company in New York, embracing a trend that has seen a swathe of entrepreneurs tapping into investor interest in new offerings, two people close to the matter said.
Palo Alto Networks, the global cybersecurity leader, is transforming the healthcare industry by enabling the organizations to improve patient and employee experience, protect patient data and improve regulatory compliance throughout the continuum of care SANTA CLARA, Calif., May 5, 2021 /PRNews
Decheng Capital and Eclipse Ventures lead Series B round, bringing total funding to over $100 million SOUTH SAN FRANCISCO, Calif., May 5, 2021 /PRNewswire/ -- Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 mil
In KESTREL and KITE, Beovu (brolucizumab) 6 mg met the primary endpoints of non-inferiority in change in best corrected visual acuity from baseline versus aflibercept 2 mg at year one in diabetic macular edema (DME) patients1
DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT WASHINGTON, April 26, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), the global science and technology company, announced today the formation of a Scientific Advisory Board ("Board") to s
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) for the adjuvant treatment of patients with surgically resected, high-risk mu
AstraZeneca’s Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the US to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced the initiation of a rolling submission of a new drug application (NDA) with the US Food and Drug Administration (FDA) for investiga
|1||Johnson & Johnson||United States|
|2||UnitedHealth Group||United States|
|3||CVS Health||United States|
|6||General Electric||United States|
The grand event, co-organized by the Ministry of Commerce and Zhejiang provincial government, is designed to explore more opportunities to boost trade in consumer goods and services with Central and Eastern European nations.
The second China-CEEC Expo will help China to share its market opportunities with the 17 Central and Eastern European countries and assist the recovery and growth of the global economy, senior government officials said on Wednesday.
Our world is changing. Whereas Great Britain ruled the waves in the 19th century, the US dominated the 20th century. And this 21st century? One thing is clear: China’s role becomes more and more important.
Michael Shanley, Director of Moller International, delivered a keynote speech at GHICC 2020
Daniel Ghinn, CEO of CREATION.co, delivered a speech at GHICC 2020
Mario Schäfer, Manager Portfolio Management Generics, Established Product at Sanofi Aventis Deutschland GmbH and Managing Director of Azeta Pharma GmbH, delivered a keynote speech at GHICC 2020
Professor Robert ZOREC，Member Academia Europaea (Lond.) & currently Vice-President Slovenian Academy of Sciences and Arts, delivered a keynote speech at GHICC 2020
He Mengsheng, Senior Advisor to Bayer, Former Vice President of Bayer Greater China, delivered a keynote speech at GHICC 2020
The event attracted approximately 300 people of more than 61 countries and regions from the Fortune Global 500, Forbes Global 2000, Global Health Industry Top 100, global top 100 industrial investors, national academies of science, world famous universities, emerging enterprises in health industry,
Zheng Xiongwei, Famous International Economist, Global Executive Chairman of APCEO, published the Cooperation Information of Global Health Industry Top 100